Cytokinetics reports positive ACACIA-HCM results for aficamten in non-obstructive HCMAug 28Clinical readoutaficamtenCytokinetics
Cytokinetics reports Q2 2026 results, ACACIA-HCM hits both primary endpointsAug 6Quarterly updateaficamtenCytokinetics
Royalty Pharma raises 2026 guidance after 14% Royalty Receipts growth in Q2Aug 5Quarterly updateRoyalty Pharma plc
Sign inSign in